Deficiency of Nmnat3 in mice does not decrease the NAD level in mitochondria. by Masashi Yamamoto (407190)

Decrease of oxidation capacity of NCT and NVC-422 in EHEC Direct Medium. by Christian Eitzinger (122449)

The VPAC1 protein level is decreased in U937 cells after 48 h from miR-525-5p transfection. by Elisa Cocco (362650)

GSPs decrease cell viability and induce cell death of HNSCC cells. by Ram Prasad (305524)

AEA and URB597 decrease cell proliferation without inducing apoptosis. by Laurie Hamtiaux (199349)

Melatonin and hypoxia/reoxygenation decrease the mitochondrial content in BeWo cells. by Lucas Sagrillo-Fagundes (6194843)

Pertussis specific levels of B_mem decrease with time. by Inonge van Twillert (503888)

SAA and saaHDL decrease adiponectin secretion by hMADS adipocytes. by Aurélie Faty (169741)

Prolonged treatment with propofol does not decrease the neural stem cell pool. by Arvind Palanisamy (3159156)

S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

HO-1 decreases MMP-1 expression and chondrocytes DNA fragmentation. by Francis Rousset (424375)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

Distribution of mean ∑PAHs (ng‧L⁻¹) in water samples from various watersheds: areas surrounding TP (a), areas surrounding China (b), and areas around the worl... by Xinyu Wen (3693)

Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

“…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

MPA decreased TEER and increased HIV transmission across polarized cells. by Susan C. Irvin (708995)

Expression of PON1 decreases superoxide levels in germ-free <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

LCN2 treatment decreases the extent of hippocampal LTP in brain slices. by Jae-Hong Kim (124622)

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”